NeoImmune Investors
NeoImmune is a developer of technologies for the reading and writing of T and B lymphocyte receptor repertoire and its medical applications.
Connections
Headquarters:
Shenzhen, Guangdong, China
Founded Date:
2019
Investor Type:
Healthcare Company
Industry:
Other